How Ozempic Supports Weight Loss

This is a plain explanation of how semaglutide affects appetite, digestion and blood sugar, and where food fits around it.

We should be clear about our position first. We are a food company. We do not prescribe, recommend or supply any medication, and there is no dosing information on this page. Our interest here is nutritional: what happens to your eating when appetite drops, and how to keep it adequate.

What Ozempic is

Ozempic is a brand of semaglutide, a GLP-1 receptor agonist. It works by mimicking GLP-1, a hormone your gut releases after eating that helps regulate blood sugar and appetite.

The Australian regulatory position is worth stating accurately, because it is often reported using American approvals. In Australia the Therapeutic Goods Administration registers Ozempic for type 2 diabetes. Semaglutide for weight management is registered separately, at a higher dose, under the brand name Wegovy. They are the same molecule at different doses with different registrations, and prescribing for weight loss is a decision for your doctor.

How it works

Appetite suppression

GLP-1 receptors in the hypothalamus help regulate hunger and fullness. Semaglutide activates them, which reduces hunger and brings fullness on earlier in a meal. Most of the reduction in what people eat comes from this.

Delayed gastric emptying

It slows the rate at which food leaves the stomach for the small intestine. That prolongs fullness after eating — and it is also why nausea and early satiety are such common early side effects. The same mechanism produces both the benefit and the discomfort.

Improved insulin sensitivity

Insulin moves glucose out of the blood and into cells. Semaglutide improves how effectively the body does this, which is the basis of its diabetes registration. Insulin resistance is both a precursor to type 2 diabetes and a factor in weight gain, so improving it matters for more than the number on the scales.

What the trials found

The evidence base most often cited is the STEP programme — Semaglutide Treatment Effect in People with Obesity — including STEP 1 and STEP 4, with STEP 4 covering people without diabetes. Average reductions of roughly 14–17% of initial body weight over 68 weeks were reported.

Two things to hold alongside that figure. Those trials used semaglutide at 2.4 mg weekly, the Wegovy dose, not Ozempic's diabetes dosing — so the headline number does not transfer directly. And every arm included structured dietary and activity support; the medication was never tested as a thing you take instead of changing how you eat.

Safety points worth knowing

Common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, usually worst in the early weeks and during dose increases, and often settling as the body adjusts. Rarer but serious effects include pancreatitis and kidney problems, which is why prescriber supervision and monitoring are part of the deal rather than an optional extra.

Weight regain after stopping is common. That is not a failure of the medication — it is what happens when an appetite intervention ends and nothing has replaced the habits underneath it.

Muscle: the part that gets least attention

Weight lost on a GLP-1 medication is not all fat. A meaningful proportion is lean tissue, including skeletal muscle, and that proportion can be higher than on slower weight loss through diet alone.

It matters because skeletal muscle is where most glucose disposal happens, so losing it works against the metabolic benefit the medication is for. Muscle also underpins strength, balance and independence, and because resting metabolic rate tracks lean mass, losing it makes regain easier later.

The mitigations are well established and dull: adequate protein spread across the day, and resistance training two or three times a week. Both are harder than they sound when you are not hungry — which is exactly the problem.

Where food fits

Appetite suppression is the mechanism, so eating less is the point. The risk is that intake falls below what is nutritionally adequate rather than merely below what is needed to lose weight.

This is the gap our meals are built for: a known quantity of protein in a volume that stays manageable when you are not hungry. Every meal is approximately 250 calories with at least 20 g of protein, under 20 g of carbohydrate and under 120 mg of sodium per 100 g, with no added sugar, artificial sweeteners or preservatives.

Whether 20 g a meal is enough for you depends on your body size, age, activity and kidney function. That is a question for a dietitian, and we offer a free 15-minute consultation with an Accredited Practising Dietitian by video or phone, valued at $49. Book at portal.coreplus.com.au/befitfood, or reach us on 1300 263 257, Monday to Friday 09:00–17:00.

Where your medicine comes from

Semaglutide is prescription-only in Australia. Shortages have driven a market in compounded and imported alternatives, and the TGA has restricted compounded GLP-1 products because they are not assessed for quality, safety or efficacy the way a registered medicine is. Anything bought without a prescription, from an overseas seller or through social media cannot be assumed to contain what the label claims.

Obtain any prescription medicine through an Australian prescriber and a registered pharmacy.

Important health information

Ozempic should be prescribed and monitored by healthcare professionals experienced in its use for weight loss and diabetes management. Close monitoring matters, particularly for anyone with a history of pancreatitis or kidney problems. Speak to your health care provider before starting, changing or stopping any medication. We also recommend speaking to your health care provider before commencing our programs, or having a chat with our our dietitians.

we make a range of documents available, including its Incident Management Policy, Complaints Management Policy and Complaints Management Form. For assistance with any of these documents, contact the Customer Service team on 1300 263 257.

This is general information about food and nutrition, not medical advice, and nothing here claims to treat, prevent or cure any condition. Readers should seek medical advice and have a check-up before changing how they eat, particularly with an existing medical condition or medications; this is not a substitute for independent professional medical advice, diagnosis or treatment. Weight loss results and rates of weight loss vary between individuals.

Questions and answers

What do we explain about How Ozempic Supports Weight Loss?

On our How Ozempic Supports Weight Loss page, we explain that this is a plain explanation of how semaglutide affects appetite, digestion and blood sugar, and where food fits around it. We should be clear about our position first. We are a food company. We do not prescribe, recommend or supply any medication , and there is no dosing information on this page. Our interest here is nutritional: what happens to your eating when appetite drops, and how to keep it adequate.

What should I know about what ozempic is on this page?

On our How Ozempic Supports Weight Loss page, we explain that ozempic is a brand of semaglutide, a GLP-1 receptor agonist. It works by mimicking GLP-1, a hormone your gut releases after eating that helps regulate blood sugar and appetite. The Australian regulatory position is worth stating accurately, because it is often reported using American approvals. In Australia the Therapeutic Goods Administration registers Ozempic for type 2 diabetes . Semaglutide for weight management is registered separately, at a higher dose, under the brand name Wegovy . They are the same molecule at different doses with different registrations, and prescribing for weight loss is a decision for your doctor.

What should I know about how it works on this page?

On our How Ozempic Supports Weight Loss page, we explain that appetite suppression GLP-1 receptors in the hypothalamus help regulate hunger and fullness. Semaglutide activates them, which reduces hunger and brings fullness on earlier in a meal. Most of the reduction in what people eat comes from this. Delayed gastric emptying It slows the rate at which food leaves the stomach for the small intestine. That prolongs fullness after eating — and it is also why nausea and early satiety are such common early side effects. The same mechanism produces both the benefit and the discomfort. Improved insulin sensitivity Insulin moves glucose out of the blood and into cells. Semaglutide improves how effectively the body does.

What should I know about what the trials found on this page?

On our How Ozempic Supports Weight Loss page, we explain that the evidence base most often cited is the STEP programme — Semaglutide Treatment Effect in People with Obesity — including STEP 1 and STEP 4, with STEP 4 covering people without diabetes. Average reductions of roughly 14–17% of initial body weight over 68 weeks were reported. Two things to hold alongside that figure. Those trials used semaglutide at 2.4 mg weekly, the Wegovy dose, not Ozempic's diabetes dosing — so the headline number does not transfer directly. And every arm included structured dietary and activity support; the medication was never tested as a thing you take instead of changing how you eat.

What should I know about safety points worth knowing on this page?

On our How Ozempic Supports Weight Loss page, we explain that common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, usually worst in the early weeks and during dose increases, and often settling as the body adjusts. Rarer but serious effects include pancreatitis and kidney problems, which is why prescriber supervision and monitoring are part of the deal rather than an optional extra. Weight regain after stopping is common. That is not a failure of the medication — it is what happens when an appetite intervention ends and nothing has replaced the habits underneath it.

What should I know about muscle: the part that gets least attention on this page?

On our How Ozempic Supports Weight Loss page, we explain that weight lost on a GLP-1 medication is not all fat. A meaningful proportion is lean tissue, including skeletal muscle, and that proportion can be higher than on slower weight loss through diet alone. It matters because skeletal muscle is where most glucose disposal happens, so losing it works against the metabolic benefit the medication is for. Muscle also underpins strength, balance and independence, and because resting metabolic rate tracks lean mass, losing it makes regain easier later. The mitigations are well established and dull: adequate protein spread across the day , and resistance training two or three times a week. Both are harder than they.

Related pages on this site

Images on This Page